There are going to be patients who need a more individualized and nuanced approach, Dr
Health regulators have approved two new GLP1 pills one from the makers of Ozempic and Wegovy and another from the makers of Mounjaro and Zepbound
Although bariatric surgery can lead to weight loss of at least 25% and long-term weight maintenance, it is not scalable at the population level, and many people are still afraid to have surgery because of the possibility of complications, [135, 136]
Side effect comparison: tirzepatide versus retatrutide Understanding the side effect differences helps you prepare for what the transition may bring
In clinical trials, participants lost an average of 14.9% of their body weight over 68 weeks (published in the New England Journal of Medicine)
Moreover, there is a need for additional studies that identify patients or sub-types of patients with various addictions who might benefit from treatment with such medications: for instance, the possibility that polymorphisms in the GLP-1R genes influence the treatment outcome of GLP-1R agonists on alcohol drinking in patients with AUD
